Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
Soin
A S
AS
University of Cambridge Clinical School, UK.
Rasmussen
A
A
Jamieson
N V
NV
Tokat
Y
Y
Watson
C J
CJ
Friend
P J
PJ
Wight
D G
DG
Calne
R Y
RY
D000293:Adolescent; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011237:Predictive Value of Tests; D012307:Risk Factors; D013256:Steroids / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine